DigestRedComo funciona
Red
/
Empresas
Th
No verificado

The Board of Directors of Sinovac Biotech Ltd.

Sobre qué escribimos

Acciones y ObligacionesBiotecnologíaFarmacéuticaSaludVIH, SIDA y enfermedades autoinmunes

16 Comunicados de prensa

Ver todos los comunicados de prensa
18/11/2025
Biotecnología
Farmacéutica
Salud
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
24/10/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
SINOVAC Announces Appointment of Independent Auditor
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
11/07/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
09/07/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
09/07/2025
Biotecnología
Farmacéutica
Salud
Acciones y Obligaciones
SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
09/07/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
07/07/2025
Multimedia
Biotecnología
Farmacéutica
Salud
Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card “AGAINST” Misguided Proposals 1 and 2
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
07/07/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
03/07/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0
02/07/2025
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Farmacéutica
Salud
Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place
Fuente
The Board of Directors of Sinovac Biotech Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0